India’s pharmaceutical industry is entering a new era of regulatory vigilance as the Central Drugs Standard Control Organisation (CDSCO) tightens it...
$31 Billion Milestone: How India’s Pharma Exports Defied Global Challenges in FY26
India’s pharmaceutical industry has once again proven its global strength by surpassing the remarkable $31 billion export mark in FY26. This achieve...
India’s Generic Powerhouse: Balancing Global Health and WTO-Compliant IP Rules
India has firmly established itself as the “pharmacy of the world,” playing a crucial role in delivering affordable medicines across continents. A...
From Generics to Global Innovation: How India’s Pharma Sector Is Entering a New Era
India’s pharmaceutical industry has long been recognized as the “pharmacy of the world,” supplying affordable generic medicines across the globe...
Revival and Resilience: How India’s Pharma Market Closed FY26 on a Strong Note
The Indian pharmaceutical market (IPM) has wrapped up FY26 with renewed momentum, signaling a clear turnaround after a period of sluggish demand. The ...
America’s 100% Pharma Tariff Shock: A Double-Edged Sword for India’s Drug Industry
The global pharmaceutical landscape has been shaken by the United States’ decision to impose a 100% tariff on patented pharmaceutical imports, a mov...
Rewriting the Rulebook: Why India Must Transform Its Drug Regulatory Framework for Global Leadership
India’s pharmaceutical industry has long been celebrated as the “pharmacy of the world,” supplying affordable medicines across continents. Yet, ...
The Semaglutide Shift: How Generics Are Unlocking Off-Label Opportunities in the Weight-Loss Market
The pharmaceutical landscape is witnessing a significant transformation with the emergence of semaglutide generics. Originally developed as a treatmen...
Gas Crisis in Pharma: How LPG Shortages Could Disrupt Life-Saving Drug Supply in India
India’s pharmaceutical industry—often called the “pharmacy of the world”—is facing an unexpected and serious challenge. A growing shortage o...
ESG-Driven Capital Transformation: Shaping the Future of Indian Pharma Growth
India’s pharmaceutical industry is undergoing a powerful transformation—one that goes far beyond innovation in medicines. Today, the sector is red...
Array
